Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1970584 | 1.00 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL1970642 | 1.00 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL12571192 | 1.00 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL1969089 | 0.90 | IDH1 (0.70) | HSD11B1IDH1 | |
| SCHEMBL12571227 | 0.90 | IDH1 (0.70) | HSD11B1IDH1 | |
| SCHEMBL1969088 | 0.90 | IDH1 (0.70) | HSD11B1IDH1 | |
| SCHEMBL1968922 | 0.89 | HSD11B1 (0.62) | HSD11B1 | |
| SCHEMBL12571230 | 0.88 | HSD11B1 (0.62) | HSD11B1IDH1 | |
| SCHEMBL2012424 | 0.88 | HSD11B1 (0.62) | HSD11B1IDH1 | |
| SCHEMBL2012421 | 0.88 | HSD11B1 (0.62) | HSD11B1IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090312372-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2009-12-17 | — | — | US | disclosed |
| US-20090312372-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312372-A1 | CHEMICAL COMPOUNDS | HSD11B1, CYP11B1, CYP4A11 | HSD11B1 1/4885IDH1 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.